
The regents are to discuss the change during their Thursday meeting. Turning university innovations into money-making products has become a priority as the university deals with falling state support.
It’s also become more urgent as the patent on the university’s most profitable product, the AIDS drug Ziagen, is set to run out in the United States in 2013.
To read the full, original article click on this link: U Of Minn. Regents Discuss Technology Transfer « CBS Minnesota – News, Sports, Weather, Traffic, and the Best of Minnesota